JP2017200474A5 - - Google Patents

Download PDF

Info

Publication number
JP2017200474A5
JP2017200474A5 JP2017090736A JP2017090736A JP2017200474A5 JP 2017200474 A5 JP2017200474 A5 JP 2017200474A5 JP 2017090736 A JP2017090736 A JP 2017090736A JP 2017090736 A JP2017090736 A JP 2017090736A JP 2017200474 A5 JP2017200474 A5 JP 2017200474A5
Authority
JP
Japan
Prior art keywords
cells
population
imp
express
detectable levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017090736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017200474A (ja
Filing date
Publication date
Priority claimed from GBGB1410504.3A external-priority patent/GB201410504D0/en
Application filed filed Critical
Publication of JP2017200474A publication Critical patent/JP2017200474A/ja
Publication of JP2017200474A5 publication Critical patent/JP2017200474A5/ja
Pending legal-status Critical Current

Links

JP2017090736A 2014-06-12 2017-04-28 免疫調節前駆(imp)細胞 Pending JP2017200474A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1410504.3A GB201410504D0 (en) 2014-06-12 2014-06-12 Immuno-modulaltory progenitor (IMP) cell
GB1410504.3 2014-06-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016515943A Division JP6185657B2 (ja) 2014-06-12 2015-06-09 免疫調節前駆(imp)細胞

Publications (2)

Publication Number Publication Date
JP2017200474A JP2017200474A (ja) 2017-11-09
JP2017200474A5 true JP2017200474A5 (cg-RX-API-DMAC7.html) 2018-07-12

Family

ID=51266501

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016515943A Active JP6185657B2 (ja) 2014-06-12 2015-06-09 免疫調節前駆(imp)細胞
JP2017090736A Pending JP2017200474A (ja) 2014-06-12 2017-04-28 免疫調節前駆(imp)細胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016515943A Active JP6185657B2 (ja) 2014-06-12 2015-06-09 免疫調節前駆(imp)細胞

Country Status (23)

Country Link
US (2) US12029763B2 (cg-RX-API-DMAC7.html)
EP (2) EP2984163B1 (cg-RX-API-DMAC7.html)
JP (2) JP6185657B2 (cg-RX-API-DMAC7.html)
KR (2) KR20160029092A (cg-RX-API-DMAC7.html)
CN (1) CN105473711A (cg-RX-API-DMAC7.html)
AU (1) AU2015273271B2 (cg-RX-API-DMAC7.html)
CA (1) CA2951492C (cg-RX-API-DMAC7.html)
CY (1) CY1119093T1 (cg-RX-API-DMAC7.html)
DK (1) DK2984163T3 (cg-RX-API-DMAC7.html)
EA (1) EA034083B1 (cg-RX-API-DMAC7.html)
ES (1) ES2622397T3 (cg-RX-API-DMAC7.html)
GB (1) GB201410504D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20170657T1 (cg-RX-API-DMAC7.html)
HU (1) HUE033392T2 (cg-RX-API-DMAC7.html)
IL (2) IL249298B (cg-RX-API-DMAC7.html)
LT (1) LT2984163T (cg-RX-API-DMAC7.html)
MA (1) MA38860B1 (cg-RX-API-DMAC7.html)
MY (1) MY181994A (cg-RX-API-DMAC7.html)
PL (1) PL2984163T3 (cg-RX-API-DMAC7.html)
PT (1) PT2984163T (cg-RX-API-DMAC7.html)
SG (1) SG11201610355PA (cg-RX-API-DMAC7.html)
WO (1) WO2015189587A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201608402B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201513996D0 (en) 2015-08-07 2015-09-23 Cell Therapy Ltd Immuno-oncology mesodermal progenitor (IOMP) cell
WO2017168170A1 (en) * 2016-03-31 2017-10-05 Cell Therapy Limited Immuno-modulatory progenitor (imp) cell expressing one or more of cd3, cd3e, cd8, cd8b, cd4, cd5, cd6 and cd7
CN109104869B (zh) * 2016-04-27 2022-07-01 日本乐敦制药株式会社 表达细胞表面标记物的间充质干细胞、包含该间充质干细胞的药物组合物及其制备方法
CN106267161A (zh) * 2016-09-30 2017-01-04 广州赛莱拉干细胞科技股份有限公司 一种干细胞制剂及其制备方法和应用
CN107184602B (zh) * 2017-06-01 2020-06-30 刘未斌 一种治疗肿瘤的药物组合
WO2019013279A1 (ja) * 2017-07-13 2019-01-17 国立大学法人 東京医科歯科大学 三次元メカノシグナル細胞培養系を用いて作製した腱/靱帯様人工組織
AU2018300272B2 (en) * 2017-07-14 2024-09-19 Orbsen Therapeutics Limited CD39 stromal stem cells methods of isolation and use
CN108660203A (zh) * 2018-05-18 2018-10-16 大连医科大学附属第医院 Cxcr2基因在心脏相关疾病中的用途
TWI807036B (zh) * 2018-05-30 2023-07-01 南韓商韓國億諾生物有限公司 用於預防或治療癌症之包含作為活性成分之cd300e抑制劑的藥學組成物
US12303534B2 (en) * 2018-06-05 2025-05-20 Medipost Co., Ltd Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
GB201900554D0 (en) 2019-01-15 2019-03-06 Cell Therapy Ltd Mesodermal killer (mk) cell
WO2020148520A1 (en) 2019-01-15 2020-07-23 Cell Therapy Limited Mesodermal killer (mk) cell
CN110314173A (zh) * 2019-07-17 2019-10-11 中国医科大学附属第一医院 一种用于治疗骨关节炎的细胞制剂及其制备方法
EP4054595A4 (en) * 2019-11-07 2023-11-15 Massachusetts Eye and Ear Infirmary Cultivated autologous limbal epithelial cell (calec) transplantation
CN116482350B (zh) * 2022-01-17 2025-10-21 上海源奇生物医药科技有限公司 用于监测急性b淋巴细胞白血病微小残留病灶的流式细胞术试剂盒及监测方法
CN120112628A (zh) * 2022-10-12 2025-06-06 希望细胞疗法株式会社 新型血管形成干细胞
JP2025534040A (ja) * 2022-10-14 2025-10-09 ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク 腱傷害の治療における使用のための胎盤発現タンパク質

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801537D0 (sv) 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
ES2729557T3 (es) 2008-05-28 2019-11-04 Univ Ramot Células madre mesenquimatosas para el tratamiento de enfermedades del SNC
WO2011053860A2 (en) 2009-10-30 2011-05-05 Allocure, Inc. Mesenchymal stromal cell populations and methods of using same
EP2506867B1 (en) * 2009-12-02 2014-10-08 Cardio3 Biosciences S.A. Pharmaceutical compositions for the stimulation of stem cells.
US20130189741A1 (en) * 2009-12-07 2013-07-25 Cellscript, Inc. Compositions and methods for reprogramming mammalian cells
WO2012052911A1 (en) 2010-10-22 2012-04-26 Nokia Corporation Method and apparatus for co-operative reception for network controlled device to device
CN104508124B (zh) * 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
EA029443B1 (ru) 2011-11-23 2018-03-30 Селл Терапи Лимитед Фармацевтическая композиция на основе лизата тромбоцитов
US9682104B2 (en) * 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
US9670457B2 (en) 2012-05-08 2017-06-06 Stem Cell Reserve Lp Stem cells and matrix from cord tissue

Similar Documents

Publication Publication Date Title
HRP20170657T1 (hr) Imunomodulatorne ishodišne (imp) stanice
JP2017517557A5 (cg-RX-API-DMAC7.html)
JP2004528806A5 (cg-RX-API-DMAC7.html)
US10316291B2 (en) Immuno-oncology mesodermal progenitor (ioMP) cell
JP2023126852A5 (cg-RX-API-DMAC7.html)
JP2019533450A5 (cg-RX-API-DMAC7.html)
US20170007644A1 (en) A method of treating neoplasia
JP2025519106A5 (cg-RX-API-DMAC7.html)
JP2024543369A (ja) Emr2修飾のための化合物及び方法
Saalmüller et al. Summary of the animal homologue section of HLDA8
AU2020209441B2 (en) Mesodermal killer (MK) cell
KR102044620B1 (ko) 면역 질환의 예방 또는 치료용 세포치료제 조성물
HK40062275A (en) Mesodermal killer (mk) cell
HK40062275B (en) Mesodermal killer (mk) cell
Jankowski et al. ISOLATION AND FUNCTIONAL ASSESSMENT OF MYOGENIC PRECURSORS IDENTIFIED VIA SURFACE PROTEIN EXPRESSION
RU2019116783A (ru) Иммунологически отличимые варианты поверхности клеток для применения в клеточной терапии
NZ727129B2 (en) Immuno-modulatory progenitor (imp) cell
WO2017168170A1 (en) Immuno-modulatory progenitor (imp) cell expressing one or more of cd3, cd3e, cd8, cd8b, cd4, cd5, cd6 and cd7